Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/25/09 → 10/31/16 |
Funding
- Bavarian Nordic: $190,866.00
A Randomized, Double-Blind, Placebo-Controlled Phase I/II Study to Evaluate the Safety and Immunogenicity of One and Two Doses of IMVAMUNE Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
- Greenberg, Richard (PI)